Intuitive Surgical Inc

Most Recent

  • uploads///DVA
    Consumer

    Lone Pine Capital starts new positions in BIDU, MA, DVA, P, Sells ISRG, RL – 13F Flash (C)

    Lone Pine Capital LLC, based in Greenwich, Connecticut, was founded in 1997 by Stephen Mandel and is one of the largest equity-focused hedge funds in the United States. It is estimated to have $28.3 billion of assets under management. In Q3 2013, it started new positions in Baidu Inc. (BIDU), MasterCard Inc. (MA), Davita Healthcare […]

    By Samantha Nielson
  • uploads///MA
    Consumer

    Lone Pine Capital starts new positions in BIDU, MA, DVA, P, Sells ISRG, RL – 13F Flash (B)

      Lone Pine Capital LLC, based in Greenwich, Connecticut, was founded in 1997 by Stephen Mandel and is one of the largest equity-focused hedge funds in the United States. It is estimated to have $28.3 billion of assets under management. In Q3 2013, it started new positions in Baidu Inc. (BIDU), MasterCard Inc. (MA), Davita […]

    By Samantha Nielson
  • uploads///black and white blood pressure blood pressure monitor
    Company & Industry Overviews

    What Are Intuitive Surgical’s Key Growth Drivers in 2019?

    In the first quarter, Intuitive Surgical (ISRG) placed 235 da Vinci systems, a YoY (year-over-year) rise of 27.03%. However, its Systems revenue in the first quarter was $248 million, a YoY rise of 6%.

    By Margaret Patrick
  • uploads///TMO
    Company & Industry Overviews

    Do Analysts See Any Upside for Thermo Fisher Stock?

    Of the 17 analysts covering Thermo Fisher Scientific (TMO), 14 recommend ” buy” or a higher rating, and three recommend “hold.”

    By Kenneth Smith
  • uploads///TMO
    Company & Industry Overviews

    Thermo Fisher Scientific’s Gross Margin Trends

    In fiscal 2018 and fiscal 2019, Thermo Fisher Scientific (TMO) is expected to generate revenue of $24.08 billion and $25.19 billion, respectively, compared with revenue of $20.92 billion in fiscal 2017.

    By Kenneth Smith
  • uploads///ISRG
    Company & Industry Overviews

    Intuitive Surgical Stock Has Seen Growth of 34% Year-to-Date

    Intuitive Surgical’s stock price rose from $364.94 at the close of market on December 29, 2017, to $489.57 on November 23, 2018.

    By Daniel Collins
  • uploads///molecule _
    Earnings Report

    How TransEnterix Has Been Performing in November

    In this series, we’ll explore TransEnterix’s financials, analyst recommendations, and valuation metrics.

    By Kenneth Smith
  • uploads///NVCR ana reco
    Earnings Report

    Gauging Analysts’ Views for NovoCure Stock

    Of the five analysts covering NovoCure (NVCR) stock in October, two have given it a “strong buy,” and three have given it a “buy.”

    By Kenneth Smith
  • uploads///ISRG RD
    Earnings Report

    How Intuitive’s Bottom Line Is Expected to Look in Q3 2018

    Intuitive Surgical’s (ISRG) cost of goods sold is expected to rise 16.82% to $265.76 million in the third quarter of 2018.

    By Kenneth Smith
  • uploads///VRAY ana reco
    Company & Industry Overviews

    What ViewRay’s Valuation Trend Indicates

    In September, of the seven analysts covering ViewRay (VRAY), six have given its stock “buy” or higher ratings, and one analyst has given it a “sell” rating.

    By Kenneth Smith
  • uploads///laboratory _
    Company & Industry Overviews

    How Quest Diagnostics Is Positioned in 2018

    Quest Diagnostics generated revenues of $1.92 billion in the second quarter of 2018 as compared with $1.86 billion in the second quarter of 2017.

    By Kenneth Smith
  • uploads///hand _
    Company & Industry Overviews

    Johnson & Johnson Advances in Robotics Surgery with Orthotaxy

    On February 20, Johnson & Johnson (JNJ) announced the acquisition of Orthotaxy to develop its robot-assisted orthopedics surgery platform.

    By Sarah Collins
  • uploads///GUIDANCE
    Earnings Report

    Will Varian Medical Systems’ Sales Decline Again in 1Q18?

    According to Wall Street analysts’ estimates, Varian Medical Systems (VAR) will report revenues of $636.8 million in 1Q18, a YoY decline of 16.6%.

    By Sarah Collins
  • uploads///GOP TAX BILL
    Healthcare

    How the Corporate Tax Rate Cut Could Affect R&D in the Medtech Industry

    The repeal of the tax deduction for high medical expenses may reduce the number of taxpayers opting for costly medical technologies and services.

    By Sarah Collins
  • uploads///etf performance
    Company & Industry Overviews

    How the Medical Expense Tax Deduction Affects the Healthcare Industry

    According to AARP, around 75% the population claiming these medical expense deductions from their income are 50 years or older.

    By Sarah Collins
  • uploads///OPERATIONAL PLANS
    Company & Industry Overviews

    Zimmer Biomet’s Plan to Revive Growth amid Supply Disruptions

    Zimmer Biomet Holdings has laid down a dual sourcing strategy to resolve production issues at its Warsaw facility.

    By Sarah Collins
  • uploads///da vinci x
    Company & Industry Overviews

    How Intuitive Surgical Is Expanding Its Da Vinci X Systems Worldwide

    Intuitive Surgical’s (ISRG) Da Vinci X received early FDA approval in May 2017 and was given a CE Mark in Europe in April 2017.

    By Sarah Collins
  • uploads///investments
    Company & Industry Overviews

    Strategic Investments Drive Intuitive Surgical’s Future Growth

    Intuitive Surgical focused on accelerating its strategic investments in recent years. It wants to expand across low-cost and untapped markets.

    By Sarah Collins
  • uploads///installed base footprints
    Company & Industry Overviews

    Intuitive Surgical Plans to Expand in Europe and Asia

    Although Intuitive Surgical leads the surgical robotics market, there are competitive threats from other major players in the market.

    By Sarah Collins
  • uploads///recommendations
    Company & Industry Overviews

    Wall Street’s Upbeat on Boston Scientific: Most Recommend a ‘Buy’

    Wall Street analysts’ lowest one-year target price for Boston Scientific (BSX) stock is $24, representing a -11.4% maximum downside risk potential for the next year.

    By Sarah Collins
  • uploads///profitability drivers
    Company & Industry Overviews

    Why Varian Medical Systems’ Profitability Is Improving

    Varian Medical Systems’ profitability In 3Q17, Varian Medical Systems reported a gross margin of approximately 44.5%, representing an 18-basis-point improvement in the quarter. YTD (year-to-date), the margin has improved by around 138 basis points. In 3Q17, the company’s Oncology Systems business witnessed a gross margin improvement of 200 basis points to reach 48.1% of the segment’s total […]

    By Sarah Collins
  • uploads///PERFORMANCE
    Earnings Report

    Key Highlights of Varian Medical Systems’ Fiscal 2Q17 Earnings

    On April 26, 2016, Varian Medical Systems (VAR) released its 2Q17 earnings. VAR beat consensus estimates for revenues in 2Q17 by ~0.8% and reported in-line earnings per share.

    By Sarah Collins
  • uploads///eps estimates
    Earnings Report

    What to Expect from Intuitive Surgical’s 2Q17 Earnings

    Analysts estimate that Intuitive Surgical will post 2Q17 EPS (earnings per share) of ~$4.76. In 1Q17, Intuitive Surgical exceeded analysts’ diluted EPS estimate of $4.67.

    By Sarah Collins
  • uploads///ma
    Company & Industry Overviews

    Zimmer Biomet’s Inorganic Growth Strategy Is Helping Performance

    In October 2016, Zimmer Biomet Holdings announced the acquisition of the RespondWell telerehabilitation platform.

    By Sarah Collins
  • uploads///MITG
    Earnings Report

    Here’s What’s Driving Medtronic’s MITG Segment

    Of Medtronic’s ~$7.3 billion in worldwide revenues in fiscal 2Q17, ~$2.5 billion came from Medtronic’s MITG segment, representing ~34% of the company’s total revenues.

    By Sarah Collins
  • uploads///forward pe
    Company & Industry Overviews

    A Look at Zimmer Biomet’s Latest Valuation

    After the release of its 2Q16 earnings results on July 28, 2016, Zimmer Biomet Holdings (ZBH) was trading at a forward price-to-earnings multiple in the range of 15.5x–16.2x.

    By Sarah Collins
  • uploads///revenue
    Earnings Report

    2Q16 Revenue Estimates for Intuitive Surgical

    On July 19, 2016, Intuitive Surgical (ISRG) will announce its 2Q16 earnings. Wall Street has estimated the company’s 2Q16 revenues will come in at ~$640 million.

    By Sarah Collins
  • uploads///growth strategy
    Company & Industry Overviews

    Growth Strategies Driving Varian Medical Systems’ Revenue

    Varian Medical Systems has ventured into the proton therapy business and has a huge product pipeline in this area. The company generated approximately $300 million through its proton therapy business in 2015.

    By Sarah Collins
  • uploads///business segments
    Company & Industry Overviews

    Where Does Varian Medical Systems Get Most of Its Revenue?

    Varian Medical Systems’ Imaging Components segment accounts for approximately 19% of the company’s total revenue. The segment reported a revenue decline of ~10% in 2015.

    By Sarah Collins
  • uploads///ISRGs history timeline
    Company & Industry Overviews

    Company Overview: An Introduction to Intuitive Surgical

    Intuitive Surgical is a pioneer of minimally invasive robotic surgery. It develops and manufactures da Vinci surgical systems and related instruments.

    By Sarah Collins
  • uploads///Portfolio Breakdown of the PLGAX
    Fund Managers

    How PLGAX’s Portfolio Has Changed

    The Principal LargeCap Growth Fund I Class A (PLGAX) invests at least 80% of its assets in equities of large-capitalization companies.

    By David Ashworth
  • uploads///recurring revenue model
    Company & Industry Overviews

    What Does Intuitive Surgical’s Business Model Look Like?

    Intuitive Surgical (ISRG) defines its business model as a “razor/razor blade” model. What does this mean?

    By Sarah Collins
  • uploads///installed base
    Company & Industry Overviews

    Exploring Intuitive Surgical’s Sales Model

    Intuitive Surgical follows a diversified sales strategy and doesn’t generate more than 10% of its revenue through any one customer.

    By Sarah Collins
  • uploads///RD expenses
    Company & Industry Overviews

    Analyzing Intuitive Surgical’s R&D Strategy and Innovations

    Intuitive Surgical is continuously enhancing its product offerings, enabling more efficient procedures through internal research and development (or R&D).

    By Sarah Collins
  • uploads///open surgery trends
    Company & Industry Overviews

    A Closer Look at Intuitive Surgical’s Business Strategy

    Intuitive Surgical aims to include a larger patient population under its MIS treatments and to provide better surgery outcomes and lower recovery times.

    By Sarah Collins
  • uploads///revenues by geography
    Company & Industry Overviews

    Understanding Intuitive Surgical’s Geographical Profile

    Intuitive Surgical (ISRG) has established geographical growth as one its major growth drivers after procedure growth.

    By Sarah Collins
  • uploads///procedure trends
    Company & Industry Overviews

    How Is Procedure Growth Driving Intuitive Surgical’s Revenue?

    The number of procedures performed using Intuitive Surgical’s da Vinci surgical system in 1Q16 rose by around 17% year-over-year.

    By Sarah Collins
  • uploads///key components of Reimbursement
    Company & Industry Overviews

    How Reimbursement Models Impact the Medical Device Industry

    Coverage, coding, and payment are essential elements to obtaining adequate reimbursement for a new medical device.

    By Sarah Collins
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.